Immunoconjugate: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 32: | Line 32: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 12:49, 18 March 2025
Immunoconjugate is a type of biological therapy that combines a monoclonal antibody with a cytotoxic drug or a radioactive particle. The monoclonal antibody binds to specific proteins or antigens on cancer cells, delivering the cytotoxic drug or radioactive particle directly to the cancer, which may help decrease damage to healthy cells. Immunoconjugates are used in the treatment of certain types of cancer.
Overview[edit]
Monoclonal antibodies are laboratory-produced molecules that can locate and bind to cancer cells wherever they are in the body. They can be used alone, or they can be used to deliver drugs, toxins, or radioactive material directly to tumor cells.
An immunoconjugate is a complex of an antibody (or an antibody fragment) linked to a second molecule, which might be a chemotherapeutic agent, a toxin, or a radioactive compound. The antibody binds to specific antigens on the surface of the cell, delivering the second molecule to the cell.
Types of Immunoconjugates[edit]
There are several types of immunoconjugates, including Antibody-drug conjugates (ADCs), Radioimmunotherapy (RIT) agents, and Immunotoxins.
Antibody-Drug Conjugates[edit]
Antibody-drug conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
Radioimmunotherapy[edit]
Radioimmunotherapy (RIT) involves the use of radioactively conjugated murine antibodies against cellular antigens. RIT allows targeted delivery of radiation to the cancer cells.
Immunotoxins[edit]
Immunotoxins are a group of protein-based therapeutics composed of a targeting moiety linked to a toxin. The targeting moiety is usually a monoclonal antibody that recognizes and binds to specific cell surface antigens.
Clinical Applications[edit]
Immunoconjugates have been used in the treatment of various types of cancers, including breast cancer, lymphoma, and leukemia. They have shown promise in clinical trials, with some immunoconjugates being approved for use by the Food and Drug Administration (FDA).
